Open-label Study of the Efficacy and Safety of VESIcare® in Patients With Overactive Bladder Symptoms
Status:
Completed
Trial end date:
2005-04-01
Target enrollment:
Participant gender:
Summary
To evaluate the safety and efficacy of solifenacin succinate in subjects with overactive
bladder symptoms (urgency, with or without urge incontinence, usually with frequency and
nocturia).